| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 2, Issue 3 129-135, Copyright © 1991 by American Association of Cancer Research
ARTICLES |
RH Nicolas, G Partington, GN Major, B Smith, AF Carne, N Huskisson and G Goodwin
Chester Beatty Laboratories, Institute of Cancer Research, London.
The protein kinase inhibitor H7 [1-5(isoquinolinesulfonyl-2-methylpiperazine)] together with a temperature shift to 42 degrees C was found to reproducibly and efficiently induce differentiation of avian erythroblasts transformed with the avian erythroblastosis virus containing v-erbA and a temperature-sensitive v-erbB oncogene. Although a temperature shift to 42 degrees C without H7 results in some elevation of globin transcripts, much higher levels of transcripts accrue when cells are incubated at 42 degrees C with H7; under such conditions, 50-70% of the cells become benzidine positive. In order to investigate the mechanism by which the differentiation occurs, we have characterized and analyzed the levels of the erythroid transcription factor EF1, originally described as a factor binding to the beta H-globin promoter. Protein sequencing of EF1 shows that it is identical to the factor Eryf1. Using a peptide antibody and DNA-binding assays, we demonstrate that EF1 is present at high levels in the nucleus of undifferentiated HD3 cells, and, although there may be a small change when the cells are shifted to 42 degrees C, incubation of the cells with H7 at 42 degrees C does not result in a further elevation commensurate with the high levels of globin transcripts. It is concluded that v-erbA and v-erbB do not repress differentiation by limiting the levels of EF1.
This article has been cited by other articles:
![]() |
A. A. Gavrilov and S. V. Razin Spatial configuration of the chicken {alpha}-globin gene domain: immature and active chromatin hubs Nucleic Acids Res., August 1, 2008; 36(14): 4629 - 4640. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chernukhin, S. Shamsuddin, S. Y. Kang, R. Bergstrom, Y.-W. Kwon, W. Yu, J. Whitehead, R. Mukhopadhyay, F. Docquier, D. Farrar, et al. CTCF Interacts with and Recruits the Largest Subunit of RNA Polymerase II to CTCF Target Sites Genome-Wide Mol. Cell. Biol., March 1, 2007; 27(5): 1631 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Briegel, P Bartunek, G Stengl, K. Lim, H Beug, J. Engel, and M Zenke Regulation and function of transcription factor GATA-1 during red blood cell differentiation Development, January 12, 1996; 122(12): 3839 - 3850. [Abstract] [PDF] |
||||
![]() |
M. Minie, T Kimura, and G Felsenfeld The developmental switch in embryonic rho-globin expression is correlated with erythroid lineage-specific differences in transcription factor levels Development, January 8, 1992; 115(4): 1149 - 1164. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |